The SUSTAIN 6 cardiovascular outcomes trial demonstrated that semaglutide significantly reduced the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes at high cardiovascular risk, many of whom were taking metformin as background therapy
You dont need a blood test to get your initial prescriptions
And, when you combine Setria with LivOn's liposomal encapsulation process, you get a very potent supplement that will be properly absorbed so it can do what it says it will, and without destroying your gut (like some supplements do)
Vision changes should be assessed promptly, as rapid improvement in blood glucose can sometimes worsen diabetic retinopathy in some patients
Evidence in Action: What Research Shows Frontiers in Endocrinology reports that GLP-1 receptor agonists influence appetite, glucose regulation, and energy balance through multiple central and peripheral pathways